Results 111 to 120 of about 4,858 (185)

BET bromodomain [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

BET bromodomain proteins [PDF]

Science-Business eXchange, 2014
openaire   +3 more sources

NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells. [PDF]

Bioconjug Chem
Sneddon MS, Tsou CJ, Fu X, Shelat AA, Pomerantz WCK.   +4 more
europepmc   +1 more source

Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding Pocket. [PDF]

ACS Med Chem Lett
Nuñez R, Bursch KL, Makowski SJ, Xue M, Cozzolino KA, Shishodia S, Keyes RF, Zhu N, Smith BC.   +8 more
europepmc   +1 more source

Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation. [PDF]

Eur J Med Chem
Scholtz CR, Doskey LC, Kandanur SGS, Vail NR, Roderick ER, Peterson EJ, Hoell ZJ, Shi K, Aihara H, Kostallari E, Shah VH, Malhi H, Pomerantz WCK.   +12 more
europepmc   +1 more source

Mechanistic insights into DNA binding by BD1 of the TAF1 tandem bromodomain module. [PDF]

Biochem J
Yadav Y, Chyne P, Sudhamalla B.
europepmc   +1 more source

BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma. [PDF]

Neuro Oncol
Vadla R, Taylor B, Miyake Y, Lin B, Kawauchi D, Miki S, Nathwani N, Jones BM, Kaur Y, Banerjee A, Pham P, Tsang J, Baldwin A, Nathanson DA, Pizzo DP, Miller CR, Furnari FB.   +16 more
europepmc   +1 more source

Inferring residue level hydrogen deuterium exchange with ReX. [PDF]

Commun Chem
Crook OM, Gittens N, Chung CW, Deane CM.
europepmc   +1 more source

New leap of BRD9 inhibitor: Imidazole substituents making BRD9 inhibitors excellent drug candidates for AML. [PDF]

Acta Pharm Sin B
Zhou E.
europepmc   +1 more source

Selectively Binding a Bromodomain [PDF]

Synfacts, 2020
openaire   +1 more source